NEW YORK (GenomeWeb) – KineMed and Pronutria Biosciences today announced a collaboration to use KineMed's proteomics platform to evaluate Pronutria's biologics.

Pronutria is developing biologics to restore cellular homeostasis for patients with muscle, neurological, liver, and metabolic disorders and will use the KineMed platform to assess the physiologic effects of its compounds in preclinical and clinical studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.